Indian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India ... Feb 21
Death of US healthcare workers hits hard... Apr 08
Biocon Biologics and Mylan announce launch of Semglee (insulin glargine injection) in the U.S. to expand access for patients living with diabetes ... Aug 31
-Advertisements-